<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2565-005X</journal-id>
<journal-title><![CDATA[Gaceta mexicana de oncología]]></journal-title>
<abbrev-journal-title><![CDATA[Gac. mex. oncol.]]></abbrev-journal-title>
<issn>2565-005X</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Oncología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2565-005X2021000400139</article-id>
<article-id pub-id-type="doi">10.24875/j.gamo.21000013</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Evaluación del impacto del comité de tumores renales en el Hospital de Oncología del CMN Siglo XXI]]></article-title>
<article-title xml:lang="en"><![CDATA[Evaluation of the impact of renal tumors committee at CMN Siglo XXI, Oncology Hospital]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Picó-Guzmán]]></surname>
<given-names><![CDATA[Francisco J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alvarado-Cabrero]]></surname>
<given-names><![CDATA[Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martín-Aguilar]]></surname>
<given-names><![CDATA[Ana E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ochoa]]></surname>
<given-names><![CDATA[Jaime]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barroso-Bravo]]></surname>
<given-names><![CDATA[Sinuhé]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Escudero-de los Ríos]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rivera]]></surname>
<given-names><![CDATA[Samuel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sotelo-Martínez]]></surname>
<given-names><![CDATA[León]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cortés-Martínez]]></surname>
<given-names><![CDATA[Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Toriz]]></surname>
<given-names><![CDATA[Narciso]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,LifeSciences Consultants Consultoría de negocios ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Oncología Siglo XXI Unidad Médica de Alta Especialidad]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Oncología Siglo XXI Unidad Médica de Alta Especialidad]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Oncología Siglo XXI Unidad Médica de Alta Especialidad]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Oncología Siglo XXI Unidad Médica de Alta Especialidad]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Oncología Siglo XXI Unidad Médica de Alta Especialidad]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af7">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Oncología Siglo XXI Unidad Médica de Alta Especialidad,]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af8">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Oncología Siglo XXI Unidad Médica de Alta Especialidad]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<volume>20</volume>
<numero>4</numero>
<fpage>139</fpage>
<lpage>147</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2565-005X2021000400139&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2565-005X2021000400139&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2565-005X2021000400139&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción y objetivo: Medir el impacto en la gestión del tratamiento del cácer renal a partir de la implementación de acciones, incluyendo el comité de tumores renales, en el Hospital de Oncología del Centro Médico Nacional (CMN) Siglo XXI.  Material y métodos: Estudio observacional retrospectivo sobre una muestra de pacientes con cáncer renal en la Unidad Médica de Alta Especialidad (UMAE), Hospital de Oncología del CMN Siglo XXI. Se seleccionaron indicadores de gestión para medir tiempo, eficiencia y nivel de cumplimiento de procesos clave en el flujo de un paciente con cáncer renal.  Resultados: Se creó una base de datos con información de 741 pacientes con variables de distintas áreas terapéuticas. Tras 5 meses, se estimó un cumplimiento promedio de 37% en los indicadores evaluados. Tras 2 a ños, un cumplimiento del 47%.  Conclusiones: La implementación de las acciones resultó en mejoras en la gestión y atención de pacientes con cáncer renal en la UMAE, Hospital de Oncología del CMN Siglo XXI, particularmente en el tiempo promedio entre referencia e inicio del tratamiento.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Background and objective: Assess changes in disease management and the treatment of renal cancer after the implementation of improvement initiatives, particularly from the Renal Tumor Board at the Oncology hospital at Centro Médico Nacional (CMN) Siglo XXI.  Material and methods: Observational and retrospective study over a sample of kidney cancer patients at CMN Siglo XXI. KPI (Key Performance Indicators) were selected to measure time, efficiency, and compliance level in patient journey key processes.  Results: A database was created with information of 741 patients with variables obtained from different therapeutic areas. After 5 months of the Renal Tumor board implementation, results showed an average compliance level of 37% in the KPIs assessed. After 2 years of the Renal Tumor Board implementation, results showed a compliance level of 47% in KPIs assessed.  Conclusions: Implementation of initiatives resulted in better kidney patient management and care at the Oncology Hospital at CMN Siglo XXI. Particularly, improvements in waiting time from reference to treatment initiation was observed.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cáncer renal]]></kwd>
<kwd lng="es"><![CDATA[Comité]]></kwd>
<kwd lng="es"><![CDATA[de tumores renales]]></kwd>
<kwd lng="es"><![CDATA[Hospital de Oncología IMSS Siglo XXI]]></kwd>
<kwd lng="es"><![CDATA[Multidisciplinario]]></kwd>
<kwd lng="en"><![CDATA[Kidney cancer]]></kwd>
<kwd lng="en"><![CDATA[Kidney tumor boards]]></kwd>
<kwd lng="en"><![CDATA[Oncology Hospital IMSS Siglo XXI]]></kwd>
<kwd lng="en"><![CDATA[Multidisciplinary team]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>Cancer Statistics [Internet]</collab>
<source><![CDATA[National Institutes of Health, National Cancer Institute]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<source><![CDATA[Global Cancer Obsevatory [sede web]]]></source>
<year></year>
<publisher-loc><![CDATA[Lyon ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization, International Agency for Research on Cancer, Global Cancer Obsevatory]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Stuver]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Schillevoort]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Zerillo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality assessment of tumor boards across an academic and community cancer network]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2018</year>
<volume>36</volume>
<numero>30</numero>
<issue>30</issue>
<page-range>s122</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<source><![CDATA[The Characteristics of an Effective Multidisciplinary Team (MDT) [Internet]]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Londres ]]></publisher-loc>
<publisher-name><![CDATA[National Health Service]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurpad]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Rathmell]]></surname>
<given-names><![CDATA[WK]]></given-names>
</name>
<name>
<surname><![CDATA[Godley]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Whang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Fielding]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A multidisciplinary approach to the management of urologic malignancies:Does it influence diagnostic and treatment decisions?]]></article-title>
<source><![CDATA[Urol Oncol]]></source>
<year>2011</year>
<volume>29</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>378-82</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Powles]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Innovation:London Cancer-multidisciplinary approach to urological cancer]]></article-title>
<source><![CDATA[Nat Rev Clin Oncol]]></source>
<year>2013</year>
<volume>10</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>609-10</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Novick]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Belldegrun]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Blute]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Chow]]></surname>
<given-names><![CDATA[GK]]></given-names>
</name>
<name>
<surname><![CDATA[Derweesh]]></surname>
<given-names><![CDATA[IH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guideline for management of the clinical T1 renal mass]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2009</year>
<volume>182</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1271-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Standard contract for cancer:specialized kidney, bladder and prostate cancer services (adult). 2013-2014]]></article-title>
<source><![CDATA[NHS England]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<collab>Renal Cancer Clinical Quality Performance Indicators, Engagement Document [Internet]</collab>
<source><![CDATA[Scottish Government]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Delivering Cancer Waiting Times [Internet]]]></article-title>
<source><![CDATA[NHS, Scottish Executive Health Department]]></source>
<year>2005</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
